Ad is loading...
ALT
Price
$8.79
Change
-$0.06 (-0.68%)
Updated
Dec 3 closing price
113 days until earnings call
TGTX
Price
$33.39
Change
-$1.70 (-4.84%)
Updated
Dec 3 closing price
90 days until earnings call
Ad is loading...

ALT vs TGTX

Header iconALT vs TGTX Comparison
Open Charts ALT vs TGTXBanner chart's image
Altimmune
Price$8.79
Change-$0.06 (-0.68%)
Volume$4.37M
CapitalizationN/A
TG Therapeutics
Price$33.39
Change-$1.70 (-4.84%)
Volume$2.48M
CapitalizationN/A
ALT vs TGTX Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALT vs. TGTX commentary
Dec 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Buy and TGTX is a StrongSell.

COMPARISON
Comparison
Dec 04, 2024
Stock price -- (ALT: $8.79 vs. TGTX: $33.39)
Brand notoriety: ALT and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 125% vs. TGTX: 76%
Market capitalization -- ALT: $625.19M vs. TGTX: $5.2B
ALT [@Biotechnology] is valued at $625.19M. TGTX’s [@Biotechnology] market capitalization is $5.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $485.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TGTX is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while TGTX’s TA Score has 3 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 4 bearish.
  • TGTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ALT is a better buy in the short-term than TGTX.

Price Growth

ALT (@Biotechnology) experienced а +4.27% price change this week, while TGTX (@Biotechnology) price change was -2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was -1.83%, and the average quarterly price growth was +8.53%.

Reported Earning Dates

ALT is expected to report earnings on Mar 27, 2025.

TGTX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.2B) has a higher market cap than ALT($625M). TGTX YTD gains are higher at: 95.492 vs. ALT (-21.867). TGTX has higher annual earnings (EBITDA): 5.82M vs. ALT (-103.19M). TGTX has more cash in the bank: 341M vs. ALT (139M). ALT has less debt than TGTX: ALT (1.77M) vs TGTX (254M). TGTX has higher revenues than ALT: TGTX (265M) vs ALT (52K).
ALTTGTXALT / TGTX
Capitalization625M5.2B12%
EBITDA-103.19M5.82M-1,772%
Gain YTD-21.86795.492-23%
P/E RatioN/A39.56-
Revenue52K265M0%
Total Cash139M341M41%
Total Debt1.77M254M1%
FUNDAMENTALS RATINGS
ALT vs TGTX: Fundamental Ratings
ALT
TGTX
OUTLOOK RATING
1..100
2423
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
7457
SMR RATING
1..100
9891
PRICE GROWTH RATING
1..100
3635
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3495

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TGTX's Valuation (85) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's Profit vs Risk Rating (57) in the Biotechnology industry is in the same range as ALT (74) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's SMR Rating (91) in the Biotechnology industry is in the same range as ALT (98) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as ALT (36) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that TGTX’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTTGTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AGRH26.05N/A
N/A
iShares Interest Rt Hdg U.S. Aggt Bd ETF
IBDS24.05N/A
N/A
iShares iBonds Dec 2027 Term Corp ETF
HYRM23.80N/A
-0.01%
Xtrackers Risk Managed USD HY Strat ETF
SELV30.72-0.08
-0.25%
SEI Enhanced Low Volatil US Lg Cap ETF
ISCV68.39-0.48
-0.70%
iShares Morningstar Small-Cap Value ETF

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-4.84%
EDIT - TGTX
45%
Loosely correlated
-9.59%
ALT - TGTX
40%
Loosely correlated
-0.68%
NTLA - TGTX
38%
Loosely correlated
-6.87%
CRNX - TGTX
38%
Loosely correlated
-1.39%
BEAM - TGTX
37%
Loosely correlated
-8.18%
More